Skip to main content
Logo der Europäischen Kommission
Deutsch
TBT - European Commission

Einzelheiten der Notifizierung

Draft Commission Implementing Decision (EU) not renewing the approval of medetomidine as an active substance for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

G/TBT/N/EU/1220

Eingangsdatum: 2026 July 08
-
Frist für Kommentare: 2026 September 06
Beschreibung
This draft Commission Implementing Decision does not renew the approval of medetomidine as an active substance for use in biocidal products of product-type 21. Medetomidine has endocrine disrupting properties that may cause adverse effects in humans in accordance with the criteria laid down in Commission Delegated Regulation (EU) 2017/2100[1]. Medetomidine therefore meets the exclusion criterion set out in Article 5(1), point (d), of Regulation (EU) No 528/2012. Alternatives are available for its use in biocidal products of product-type 21. None of the derogation criteria under Article 5(2) of the BPR are considered met. It is therefore appropriate not to renew the approval of medetomidine as an active substance for use in biocidal products of product-type 21. The opinion of the European Chemicals Agency can be found on its website (Biocidal Products Committee opinions on active substance approval - ECHA (europa.eu).
Ziele:
  • Umweltschutz
Tätigkeitsbereiche:
  • Produkte der chemischen Industrie
Vollständge Fassung des Notizifierungsformulars:
Vollständge Fassung des notifizerten Textes oder anderer sachdienlicher Texte:
Kommentare, Antworten oder Reaktionen:
Disclaimer: Please note that the information published is not necessarily comprehensive. In particular, documents of notifications dated before 1 January 2014, and comments and answers received or sent on TBT notifications before 1 January 2018 are not publicly available due to data protection requirements. Some comments and answers received or sent after 1 January 2018 may be unavailable also for data protection reasons.